As COL10A1-enriched tumors feature increased immune cell infiltration and extracellular matrix components, we assume that CRC COL10A1 activation might either modulate the tumor microenvironment, or vice versa; its expression is a downstream signal of altered immune and stromal environmental interactions. The gene discussed is COL10A1; the disease is neoplasm.